Contract Research Organizations Are Seeking Transformation in the Pharmaceutical Value Chain

被引：2
|
作者：
Huang, Jianan [1 ]
机构：
[1] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou ZJ571, Zhejiang, Peoples R China
来源：
ACS MEDICINAL CHEMISTRY LETTERS | 2019年 / 10卷 / 05期
关键词：
Contract Research Organization; supply chain disruption; decision-tree model; risk-sharing; value chain;
D O I：
10.1021/acsmedchemlett.9b00046
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Since the beginning, Contract Research Organizations (CROs) have always faced two core challenges: low profit margin and limited market capitalization. Nowadays, the CRO industry is experiencing a supply chain disruption, driving it to chase the upstream part of the pharmaceutical value chain. A 3P (past, present, prospect) decision-tree model is developed, revealing the future of the CRO industry may be a CRO-Venture model. Perspectives on the potential transformation of CRO industry will contribute to the real-world practice and innovation of this business model.
引用
收藏
页码：684 / 686
页数：5
相关论文
共 50 条
12345